|
|
|
Volumn 42, Issue 1, 2001, Pages 154-161
|
|
Evaluation of 99mTc-RP128 as a potential inflammation imaging agent: Human dosimetry and first clinical results
a
|
|
Author keywords
99mTc RP128; Inflammation; Peptides; Tuftsin
|
|
Indexed keywords
CHELATING AGENT;
PEPTIDE HORMONE;
RP 128;
TECHNETIUM 99M;
TECHNETIUM RP 128 TC 99M;
TUFTSIN;
UNCLASSIFIED DRUG;
DIAGNOSTIC AGENT;
OLIGOPEPTIDE;
RADIOPHARMACEUTICAL AGENT;
TECHNETIUM COMPLEX;
TECHNETIUM TC 99M RP128;
ADULT;
ARTICLE;
BLADDER WALL;
CLINICAL TRIAL;
DIAGNOSTIC IMAGING;
DOSE CALCULATION;
DOSIMETRY;
DRUG ACCUMULATION;
DRUG CLEARANCE;
DRUG DISTRIBUTION;
DRUG SAFETY;
DRUG STRUCTURE;
GASTROINTESTINAL TRACT;
HUMAN;
HUMAN EXPERIMENT;
INFLAMMATION;
MALE;
NORMAL HUMAN;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
FEMALE;
JOINT;
PHASE 1 CLINICAL TRIAL;
RADIOMETRY;
SCINTISCANNING;
SENSITIVITY AND SPECIFICITY;
TISSUE DISTRIBUTION;
ADULT;
ARTHRITIS, RHEUMATOID;
FEMALE;
HUMANS;
JOINTS;
MALE;
OLIGOPEPTIDES;
ORGANOTECHNETIUM COMPOUNDS;
RADIOMETRY;
RADIOPHARMACEUTICALS;
SENSITIVITY AND SPECIFICITY;
TISSUE DISTRIBUTION;
|
|
EID: 0034746373
PISSN: 01615505
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (33)
|
|
References (15)
|
